1. Home
  2. MNPR vs IONR Comparison

MNPR vs IONR Comparison

Compare MNPR & IONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNPR
  • IONR
  • Stock Information
  • Founded
  • MNPR 2014
  • IONR 2001
  • Country
  • MNPR United States
  • IONR Australia
  • Employees
  • MNPR N/A
  • IONR N/A
  • Industry
  • MNPR Biotechnology: Pharmaceutical Preparations
  • IONR
  • Sector
  • MNPR Health Care
  • IONR
  • Exchange
  • MNPR Nasdaq
  • IONR Nasdaq
  • Market Cap
  • MNPR 249.5M
  • IONR 262.0M
  • IPO Year
  • MNPR 2019
  • IONR N/A
  • Fundamental
  • Price
  • MNPR $31.73
  • IONR $3.40
  • Analyst Decision
  • MNPR Strong Buy
  • IONR
  • Analyst Count
  • MNPR 5
  • IONR 0
  • Target Price
  • MNPR $59.50
  • IONR N/A
  • AVG Volume (30 Days)
  • MNPR 18.2K
  • IONR 6.3K
  • Earning Date
  • MNPR 05-13-2025
  • IONR 01-01-0001
  • Dividend Yield
  • MNPR N/A
  • IONR N/A
  • EPS Growth
  • MNPR N/A
  • IONR N/A
  • EPS
  • MNPR N/A
  • IONR N/A
  • Revenue
  • MNPR N/A
  • IONR N/A
  • Revenue This Year
  • MNPR N/A
  • IONR N/A
  • Revenue Next Year
  • MNPR N/A
  • IONR N/A
  • P/E Ratio
  • MNPR N/A
  • IONR N/A
  • Revenue Growth
  • MNPR N/A
  • IONR N/A
  • 52 Week Low
  • MNPR $1.72
  • IONR $3.02
  • 52 Week High
  • MNPR $54.30
  • IONR $9.35
  • Technical
  • Relative Strength Index (RSI)
  • MNPR 37.28
  • IONR 41.65
  • Support Level
  • MNPR $34.02
  • IONR $3.35
  • Resistance Level
  • MNPR $36.82
  • IONR $3.67
  • Average True Range (ATR)
  • MNPR 3.54
  • IONR 0.17
  • MACD
  • MNPR -0.71
  • IONR -0.00
  • Stochastic Oscillator
  • MNPR 27.91
  • IONR 30.43

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

About IONR ioneer Ltd

Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S.-based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.

Share on Social Networks: